Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 8,080,575

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,080,575
Title:Gamma-lactam compounds for promoting bone growth
Abstract: The present invention provides compounds, compositions and methods for promoting bone growth. Compounds useful in the methods of the present invention include compounds of Formula I, wherein each R.sup.1 and R.sup.2 is H, halogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, C.sub.1-6 haloalkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.1-6 haloalkoxy, --OR.sup.4, --NR.sup.4R.sup.5, --SR.sup.4, --C(O)R.sup.4, --C(O)OR.sup.4, --C(O)NR.sup.4R.sup.5, --N(R.sup.4)C(O)R.sup.5, --N(R.sup.4)C(O)OR.sup.5, --N(R.sup.4)C(O)NR.sup.4R.sup.5, --OP(O)(OR.sup.4).sub.2, --S(O).sub.2OR.sup.4, --S(O).sub.2NR.sup.4R.sup.5, --CN, cycloalkyl, heterocycloalkyl, aryl or heteroaryl. Each R.sup.4 and R.sup.5 is H or C.sub.1-6 alkyl. X is O, S or NR.sup.4. Y is an aryl ring system having 6-10 ring members or a heteroaryl ring system having 5-10 ring members where 1-3 ring members are each N, O or S. Subscript n is 1 or 2. The compounds also include salts, hydrates and isomers of the compounds of the present invention.
Inventor(s): Ellies; Debra (Parkville, MO), Rosenberg; William (Overland Park Drive, KS)
Assignee: Osteogenex Inc. (Kansas City, KS)
Application Number:12/472,134
Patent Claims:see list of patent claims

Details for Patent 8,080,575

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen, Inc. PROLIA denosumab Injection 125320 2010-06-01 ⤷  Try it Free 2028-05-29
Amgen, Inc. XGEVA denosumab Injection 125320 2010-11-18 ⤷  Try it Free 2028-05-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.